AL
Last reporting period 30 Jun, 2020
Updated —
Last price
—
Market cap $B
0.014
Exchange
XPAR - Euronext Paris
-0.0012 B
Last period CFO ,EUR
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Theradiag
Company Analysis
ALTER.PA valuation, rating, competitors, insights and company profile
Eyestock Rating
ALTER.PA financial analysis by Eyestock methodology
Valuation
ALTER.PA valuation using historical relative method
Statements
ALTER.PA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ALTER.PA dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Theradiag`s CFO for the period ended 2020-06-30 is -0.0012 B EUR
